Select country change
Shopping cart (0 , 0,00 ) Menu Search
Manufactured by BioVendor

sCD23 Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:BLAST 2, FC epsilon RII, IgE binding factor, IgE receptor lymphocyte, Immunoglobulin E receptor low affinity II
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price


RAF089R 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Sandwich ELISA, Biotin-labelled antibody

Applications

Serum, Plasma, Cell culture supernatant

Sample Requirements

100 µl/well

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

12.5–400 U/ml

Limit of Detection

6.8 U/ml

Intra-assay (Within-Run)

CV = 4.0%

Inter-assay (Run-to-Run)

CV = 6.3%

Spiking Recovery

92,50%

Dilutation Linearity

99,70%

Summary

Research topic

Cell surface proteins (sCD), Oncology

Summary

CD23 is described as a 45 kD protein found on the surface of IgM bearing B cells, eosinophils, macrophages and some T and NK cells. It is also found on EBV-transformed B cells. Additionally, a released form has been described. When first released the CD23 molecule is 35 kD; however, this form is quickly cleaved to obtain the more stable, soluble form which is 25 kD in size. Recently the structure of the CD23 molecule was characterized by cloning and sequencing techniques. Soluble CD23 has been shown to be the B cell growth factor (BCGF). Soluble CD23 is also referred to as Blast-2 and as the low affinity IgE
receptor (FCeRII). It has been speculated that CD23 may upregulate IgE synthesis in conjunction with T cell promoted interleukin-4; however, the specific physiologic role of this molecule is not yet well understood.
Elevated levels of CD23 have been found in research studies of samples from people with B cell-derived Chronic Lymphocytic Leukemia (B-CLL), with Hyper IgE Syndrome and post-Bone Marrow Transplantation samples. CD23 levels may be proven to relate to disease course in Hairy Cell Leukemia (HCL).

Related Products Documents